The current evidence shows that levels of secreted CTRP1, YKL-40, and SFRP-4 from EAT or PAT are elevated in CAD patients, whereas those of CTRP9 and Metrnl are lower relative to NCAD patients. This evidence concerns the gene C1QTNF9 and coronary artery disorder.